Key points are not available for this paper at this time.
O sarilumabe demonstrou eficácia significativa em alcançar remissão sustentada e reduzir a dose cumulativa de glucocorticoides em pacientes com recidiva de polimialgia reumática durante a redução de glucocorticoides. (Financiado pela Sanofi e Regeneron Pharmaceuticals; número do ClinicalTrials.gov SAPHYR, NCT03600818.)
Building similarity graph...
Analyzing shared references across papers
Loading...
Robert Spiera
Hospital for Special Surgery
Sebastian Unizony
Harvard University
Kenneth J. Warrington
Mayo Clinic
New England Journal of Medicine
Harvard University
Cornell University
Massachusetts General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Spiera et al. (Quarta-feira,) estudaram essa questão.
synapsesocial.com/papers/69daa3232d871caad68358b8 — DOI: https://doi.org/10.1056/nejmoa2303452